These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29152546)

  • 1. Advances in Behavioral Laboratory Methods that Inform Tobacco Regulatory Science: A TCORS Working Group Special Issue.
    Wright MJ; Valentine G
    Tob Regul Sci; 2016 Oct; 2(4):294-300. PubMed ID: 29152546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on Youth and Young Adult Tobacco Use, 2013-2018, From the Food and Drug Administration-National Institutes of Health Tobacco Centers of Regulatory Science.
    Perry CL; Creamer MR; Chaffee BW; Unger JB; Sutfin EL; Kong G; Shang C; Clendennen SL; Krishnan-Sarin S; Pentz MA
    Nicotine Tob Res; 2020 Jun; 22(7):1063-1076. PubMed ID: 31127298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of tobacco regulatory science research on vulnerable populations.
    Higgins ST; Kurti AN; Palmer M; Tidey JW; Cepeda-Benito A; Cooper MR; Krebs NM; Baezconde-Garbanati L; Hart JL; Stanton CA
    Prev Med; 2019 Nov; 128():105709. PubMed ID: 31054904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH Tobacco Research and the Emergence of Tobacco Regulatory Science.
    Meissner HI; Sharma K; Mandal RJ; Garcia-Cazarin M; Wanke KL; Moyer J; Liggins C
    Nicotine Tob Res; 2022 Mar; 24(4):463-468. PubMed ID: 34624889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science.
    LeSage MG; Smethells JR; Harris AC
    Behav Anal (Wash D C); 2018 Aug; 18(3):252-274. PubMed ID: 30214916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FDA "Deeming Rule" and Tobacco Regulatory Research.
    Backinger CL; Meissner HI; Ashley DL
    Tob Regul Sci; 2016 Jul; 2(3):290-293. PubMed ID: 29423429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products.
    Ashley DL; Backinger CL; van Bemmel DM; Neveleff DJ
    Nicotine Tob Res; 2014 Aug; 16(8):1045-9. PubMed ID: 24638850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral Economic Laboratory Research in Tobacco Regulatory Science.
    Tidey JW; Cassidy RN; Miller ME; Smith TT
    Tob Regul Sci; 2016 Oct; 2(4):440-451. PubMed ID: 28580378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Tobacco Regulatory Science Competencies.
    Wipfli HL; Berman M; Hanson K; Kelder S; Solis A; Villanti AC; Ribeiro CM; Meissner HI; Anderson R
    Nicotine Tob Res; 2017 Feb; 19(2):222-230. PubMed ID: 27613917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCORS set to support the FDA's regulatory role: program designed to generate tobacco-related research to inform policy.
    Printz C
    Cancer; 2014 Mar; 120(6):771-2. PubMed ID: 24595674
    [No Abstract]   [Full Text] [Related]  

  • 11. Communication Regulatory Science: Mapping a New Field.
    Noar SM; Cappella JN; Price S
    Health Commun; 2019 Mar; 34(3):273-279. PubMed ID: 29236531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research priorities and infrastructure needs of the Family Smoking Prevention and Tobacco Control Act: science to inform FDA policy.
    Leischow SJ; Zeller M; Backinger CL
    Nicotine Tob Res; 2012 Jan; 14(1):1-6. PubMed ID: 22184581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a comprehensive policy on nicotine delivery products and harm reduction.
    Solyst J
    Food Drug Law J; 2012; 67(4):393-404, i. PubMed ID: 24640613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of harmful and potentially harmful constituents in the implementation of the 2009 US Family Smoking Prevention and Tobacco Control Act.
    Solyst J
    Drug Test Anal; 2023 Oct; 15(10):1198-1204. PubMed ID: 36094139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An author topic analysis of tobacco regulation investigators.
    Li DC; Okamoto J; Leischow S; Liu H
    AMIA Jt Summits Transl Sci Proc; 2014; 2014():70. PubMed ID: 25717403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: A national phone survey of U.S. adults, 2014-2015.
    Boynton MH; Agans RP; Bowling JM; Brewer NT; Sutfin EL; Goldstein AO; Noar SM; Ribisl KM
    BMC Public Health; 2016 Jun; 16():516. PubMed ID: 27333921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop.
    Chang CM; Cheng YC; Cho TM; Mishina EV; Del Valle-Pinero AY; van Bemmel DM; Hatsukami DK
    Nicotine Tob Res; 2019 Jan; 21(1):3-13. PubMed ID: 29253243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco Product Use and Associated Factors Among Middle and High School Students - 
United States, 2019.
    Wang TW; Gentzke AS; Creamer MR; Cullen KA; Holder-Hayes E; Sawdey MD; Anic GM; Portnoy DB; Hu S; Homa DM; Jamal A; Neff LJ
    MMWR Surveill Summ; 2019 Nov; 68(12):1-22. PubMed ID: 31805035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model use.
    Behrsing H; Raabe H; Manuppello J; Bombick B; Curren R; Sullivan K; Sethi S; Phipps R; Tesfaigzi Y; Yan S; D'Ruiz C; Tarran R; Constant S; Phillips G; Gaça M; Hayden P; Cao X; Mathis C; Hoeng J; Braun A; Hill E
    Altern Lab Anim; 2016 May; 44(2):129-66. PubMed ID: 27256455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.